Webinar: Understanding the Challenges in Diagnosis and Implications on Women's Health
Focus on Antiphospholipid Syndrome and Preeclampsia
Learning objectives:
Discuss challenges women face in healthcare and the impact diagnostic testing can play on preventative and chronic health issues.
Recognize how appropriate diagnostic testing profiles can help avoid patient risk due to missed or delayed identification of APS.
Understand how the placental biomarkers, sFlt-1/PlGF relate to the pathogenesis of preeclampsia.
Discuss the PRAECIS study which was used to obtain FDA approval of sFlt-1/PlGF for use in patients with hypertensive disorders of pregnancy.
Understand the FDA intended use of sFlt-1/PlGF to stratify risk for patients with hypertensive disorders of pregnancy developing severe preeclampsia within 2 weeks of presentation.